IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Mechanisms that degrade inflammatory mRNAs are well known; however, stabilizing mechanisms are poorly understood. Here, we show that Act1, an interleukin-17 (IL-17)-receptor-complex adaptor, binds and stabilizes mRNAs encoding key inflammatory proteins. The Act1 SEFIR domain binds a stem-loop structure, the SEFIR-binding element (SBE), in the 3' untranslated region (UTR) of Cxcl1 mRNA, encoding an inflammatory chemokine. mRNA-bound Act1 directs formation of three compartmentally distinct RNA-protein complexes (RNPs) that regulate three disparate events in inflammatory-mRNA metabolism: preventing mRNA decay in the nucleus, inhibiting mRNA decapping in P bodies and promoting translation. SBE RNA aptamers decreased IL-17-mediated mRNA stabilization in vitro, IL-17-induced skin inflammation and airway inflammation in a mouse asthma model, thus providing a therapeutic strategy for autoimmune diseases. These results reveal a network in which Act1 assembles RNPs on the 3' UTRs of select mRNAs and consequently controls receptor-mediated mRNA stabilization and translation during inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HuR, in cooperation with Act1, promotes Cxcl1 stability in part by sterically displacing the destabilizing RBP ASF:SF2 on the 3’ UTR”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Herjan et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, Act1 itself also functions as an RBP in cooperation with HuR, binding IL-17-induced mRNA transcripts via its SEFIR domain”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Herjan et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742 · cited 1×
“Interleukin 17 (IL-17, also known as IL-17A) is a key signature cytokine of T H 17 cells and is also produced by innate immune cells 1, 2, 3 .”
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“Interleukin 17 (IL-17, also known as IL-17A) is a key signature cytokine of T H 17 cells and is also produced by innate immune cells 1, 2, 3 .”
Innate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578 · cited 1×
“Interleukin 17 (IL-17, also known as IL-17A) is a key signature cytokine of T H 17 cells and is also produced by innate immune cells 1, 2, 3 .”
Brennan, C. M., & Steitz*, J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000854 · Cited by 1,095 · cited 2×
“Although ARE binding protein SF2 (Splicing factor 2) and HuR (human antigen R) were previously implicated in IL-17-induced mRNA stabilization, the recruitment of SF2 and HuR cannot explain the receptor-specific mRNA stabilization of select inflammatory genes 19, 20 .”
Ruzankina, Y., Pinzon-Guzman, C., Asare, A., Ong, T., Pontano, L., Cotsarelis, G., Zediak, V. P., Velez, M., Bhandoola, A., & Brown, E. J. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.03.002 · Cited by 795 · cited 1×
“LSL–HA–Act1 knock-in mice were bred onto UBC-Cre-ERT2 mice 45 .”
Regulation of cytoplasmic mRNA decay
Schoenberg, D. R., & Maquat, L. E. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3160 · Cited by 656 · cited 1×
“The AREs within the 3’ UTRs can be recognized by RNA binding proteins (including TTP, AUF1, KSRP and SF2) that function to mediate the sequential deadenylation, decapping, and ultimately exonucleolytic degradation of the RNA 16, 17 .”
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 3×
“Act1 (encoded by the gene TRAF3IP2, also known as CIKS) is an essential component in IL-17 signaling and also a member of the SEFIR protein family 10, 11, 12 .”
Self-citationIL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595 · cited 14×
“IL-17-Act1-mediated signaling results in transcription of pro-inflammatory and neutrophil-mobilizing cytokines and chemokines, including Cxcl1, Tnf, Il-6 and Csf2 13 .”
InfluentialSelf-citationCutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570 · cited 4×
“Both IL-17RA and IL-17RC belong to a SEFIR protein family, which is defined by the presence of a conserved cytoplasmic SEFIR domain 9 .”
InfluentialStress granules, P-bodies and cancer
Anderson, P., Kedersha, N., & Ivanov, P. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.009 · Cited by 409 · cited 1×
“Messenger RNAs that are not engaged in translation can aggregate into cytoplasmic mRNP granules referred to as P-bodies and stress granules 21, 22 .”
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“These RBPs bind 3’ UTR motifs and counteracting the activity of de-stabilizing ribonucleases (see below) (Amatya et al., 2018; Herjan et al., 2013; Puel and Casanova, 2018).”
BackgroundInfluentialIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“In addition, Act1 has E3 ligase activity, and can bind directly to RNA, providing the necessary conditions for IL-17induced transcription and post-transcriptional activation of target genes.(40,41) Thus, blocking IL-17R-specific binding to Act1 effectively attenuates IL-17-mediated diseases.”
BackgroundInfluentialThe role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Self-citationBiology of Interleukin-17 and Its Pathophysiological Significance in Sepsis
Ge, Y., Huang, M., & Yao, Y.-M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01558 · Cited by 179
“Furthermore, several studies have identified NF-κB activator 1 (Act1) as a key adapter molecule for TRAF-6 recruitment in the induction of IL-17R signaling (27).”
Background
Metadata
- Authors
- Herjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., Zhou, H., Zhao, J., Vasu, K., Cockman, E., Aronica, M., Asosingh, K., Licatalosi, D. D., Qin, J., Fox, P. L., Hamilton, T. A., Driscoll, D., & Li, X.
- Affiliations
- Jagiellonian University (PL)
- Cleveland Clinic (US)
- Case Comprehensive Cancer Center (US)
- Corresponding author
- Li, Xiao
- Li, Xiaoxia
- ORCID
- Venue
- Nature Immunology
- Published
- 2018-03-21
- Volume
- 19
- Issue
- 4
- Pages
- 354-365
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC6082628
- OpenAlex
- W2792953869
- Cited by
- 121
- References
- 49
- Citations by year
- 2026: 11 · 2025: 6 · 2024: 12 · 2023: 15 · 2022: 28 · 2021: 20 · 2020: 13 · 2019: 13 · 2018: 3
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Funders
- National Heart, Lung, and Blood Institute (P01HL103453, U10HL109250, P01HL029582)
- National Cancer Institute (P01CA062220)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Act1, interleukin-17 receptor, mRNA stabilization, 3' untranslated region, protein-RNA complex, P-bodies, mRNA decapping, mRNA degradation, CXCL1, chemokines, translational regulation, skin inflammation, airway inflammation, asthma, autoimmune disease, RNA aptamers
- MeSH terms
- Animals, Gene Expression Regulation, Inflammation, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Interleukin-17, RNA Stability, Adaptor Proteins, Signal Transducing, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. https://app.cochat.ai/papers/10.1038/s41590-018-0071-9
- The paper
- Herjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., Zhou, H., Zhao, J., Vasu, K., Cockman, E., Aronica, M., Asosingh, K., Licatalosi, D. D., Qin, J., Fox, P. L., . . . Li, X. (2018). IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nature Immunology. https://doi.org/10.1038/s41590-018-0071-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.